FDA issues PML warning for MS patients taking Gilenya
FDA issues PML warning for MS patients taking Gilenya
Following reports of progressive multifocal leukoencephalopathy among patients taking Gilenya for multiple sclerosis, the FDA has issued a warning of possible infection for those prescribed the immunosuppressant drug.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 13717 Views
-
Last post by gibbledygook
-
- 4 Replies
- 2415 Views
-
Last post by JohnC777
-
- 0 Replies
- 1510 Views
-
Last post by frodo
-
- 0 Replies
- 1505 Views
-
Last post by NHE
-
- 0 Replies
- 2282 Views
-
Last post by frodo